Literature DB >> 9660053

Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients.

R Froissart1, I Maire, G Millat, S Cudry, A M Birot, V Bonnet, O Bouton, D Bozon.   

Abstract

We studied 70 unrelated Hunter patients and found a gene alteration in every patient. The molecular heterogeneity was very important. Large gene rearrangements were identified in 14 patients. Forty-three different mutations were identified in the 56 other patients and 31 were not previously described. Deletions and insertions, splice site mutations were associated with a severe phenotype as nonsense mutations except Q531X. Only a few mutations were present in several patients making difficult genotype-phenotype correlations. Mutation identification allows accurate carrier detection improving prenatal diagnosis. The mother was not found to be a carrier in five cases among the 44 sporadic cases. Haplotype analysis demonstrated a higher frequency of mutations in male meiosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660053     DOI: 10.1111/j.1399-0004.1998.tb02746.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  20 in total

1.  Health-Related Quality of Life in Patients with MPS II.

Authors:  Mary Needham; Wendy Packman; Natasha Quinn; Maxwell Rappoport; Christa Aoki; Alan Bostrom; Matthew Cordova; Sandra Macias; Cynthia Morgan; Seymour Packman
Journal:  J Genet Couns       Date:  2014-11-14       Impact factor: 2.537

2.  Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II).

Authors:  Jui-Hung Chang; Shuan-Pei Lin; Shu-Chuan Lin; Kai-Li Tseng; Chia-Ling Li; Chih-Kuang Chuang; Guey-Jen Lee-Chen
Journal:  Hum Genet       Date:  2004-12-22       Impact factor: 4.132

3.  Clinical and Genetic Characteristics of Romanian Patients with Mucopolysaccharidosis Type II.

Authors:  Camelia Alkhzouz; Cecilia Lazea; Simona Bucerzan; Ioana Nascu; Eva Kiss; Carmencita Lucia Denes; Paula Grigorescu-Sido
Journal:  JIMD Rep       Date:  2016-06-29

4.  Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations.

Authors:  S Alves; M Mangas; M J Prata; G Ribeiro; L Lopes; H Ribeiro; J Pinto-Basto; M Reis Lima; L Lacerda
Journal:  J Inherit Metab Dis       Date:  2006-10-25       Impact factor: 4.982

5.  Deep Genotyping of the IDS Gene in Colombian Patients with Hunter Syndrome.

Authors:  Johanna Galvis; Jannet González; Alfredo Uribe; Harvy Velasco
Journal:  JIMD Rep       Date:  2015-02-15

6.  Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II.

Authors:  Tomomi Kato; Zenichiro Kato; Izumi Kuratsubo; Noboru Tanaka; Tabito Ishigami; Jun-Ichi Kajihara; Kazuko Sukegawa-Hayasaka; Koji Orii; Koji Isogai; Toshiyuki Fukao; Nobuyuki Shimozawa; Tadao Orii; Naomi Kondo; Yasuyuki Suzuki
Journal:  J Hum Genet       Date:  2005-08-30       Impact factor: 3.172

7.  Enzyme Replacement Therapy in Mucopolysaccharidosis II Patients Under 1 Year of Age.

Authors:  Christina Lampe; Andrea Atherton; Barbara K Burton; Maria Descartes; Roberto Giugliani; Dafne D G Horovitz; Sandra O Kyosen; Tatiana S P C Magalhães; Ana Maria Martins; Nancy J Mendelsohn; Joseph Muenzer; Laurie D Smith
Journal:  JIMD Rep       Date:  2014-02-11

8.  Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome.

Authors:  S Keeratichamroen; J R Ketudat Cairns; D Wattanasirichaigoon; P Wasant; L Ngiwsara; P Suwannarat; S Pangkanon; J Kuptanon; P Tanpaiboon; T Rujirawat; S Liammongkolkul; J Svasti
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.982

9.  Review of the use of idursulfase in the treatment of mucopolysaccharidosis II.

Authors:  T Andrew Burrow; Nancy D Leslie
Journal:  Biologics       Date:  2008-06

10.  A click-flipped enzyme substrate boosts the performance of the diagnostic screening for Hunter syndrome.

Authors:  Markus Schwarz; Philipp Skrinjar; Michael J Fink; Stefan Kronister; Thomas Mechtler; Panagiotis I Koukos; Alexandre M J J Bonvin; David C Kasper; Hannes Mikula
Journal:  Chem Sci       Date:  2020-10-23       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.